IP Library › Granted Patent US 7,157,555
Granted Patent B1
US 7,157,555 · App. 10/181,102 · Granted Jan 2, 2007

Exendin agonist compounds

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,157,555
App. No.
10/181,102
Granted
Jan 2, 2007
Kind
B1
Abstract

Novel exendin peptide compounds are provided.

Claims (4)

1. An exendin peptide compound of SEQ. ID NO: 6.

2. The composition comprising a compound of claim 1 in a pharmaceutically acceptable carrier.

3. An exendin peptide compound of SEQ ID NO:10.

4. The composition comprising a compound of claim 3 in a pharmaceutically acceptable carrier.

Assignments (3)
AMYLIN PHARMACEUTICALS, LLC ASSIGNS AN EQUAL AND UNDIVIDED ONE-HALF OF ITS ENTIRE RIGHT, TITLE AND INTEREST TO ASTRAZENECA PHARMACEUTICALS LP Recorded Oct 26, 2012
From: AMYLIN PHARMACEUTICALS, LLC
To: ASTRAZENECA PHARMACEUTICALS LP
Reel/Frame 029195/0555 →
CHANGE OF NAME Recorded Oct 25, 2012
From: AMYLIN PHARMACEUTICALS, INC.
To: AMYLIN PHARMACEUTICALS, LLC
Reel/Frame 029198/0340 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 27, 2003
From: ROBERT, NIGEL; BEELEY, ARNOLD; PRICKETT, KATHRYN S.
To: AMYLIN PHARMACEUTICALS, INC.
Reel/Frame 014169/0465 →